India's pharmaceutical industry faces scrutiny as contaminated drugs cause public health concerns. Calls for stricter regulations and a comprehensive overhaul of the regulatory system grow louder.

Beneath the surface of the noble Jan Aushadhi scheme lies a tangled web of corruption, unethical practices, and challenges that have left the most marginalised population still grappling with the burden of exorbitant medical expenses and compromised health.